HIV ANTI-CD40.ENV GP140

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV ANTI-CD40.ENV GP140

Drug Alias NameCD40-targeted vaccine (LinKinVax)anti-CD40.Env-gp140 vaccine (LinKinVax)gp140-anti-CD40 antibody (LinKinVax)

ClassificationCell and gene therapy > Cell therapyVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Dendritic cell vaccine

Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 modulators

TargetsTumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesLinKinVax

China Registration ClassN/A

Develop Information

Active CompaniesLinKinVax

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A